We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.55%
4 Consumer Discretionary 5.99%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRBY icon
2651
Warby Parker
WRBY
$3.39B
-63,000
Closed -$1.74M
WSBC icon
2652
WesBanco
WSBC
$3.92B
-55,167
Closed -$1.76M
WTW icon
2653
Willis Towers Watson
WTW
$31.8B
-3,742
Closed -$1.29M
WWD icon
2654
Woodward
WWD
$20.3B
-14,554
Closed -$3.68M
WWW icon
2655
Wolverine World Wide
WWW
$1.72B
-35,660
Closed -$979K
WYNN icon
2656
CALL
Wynn Resorts
WYNN
$10.3B
-6,000
Closed -$770K
WYNN icon
2657
PUT
Wynn Resorts
WYNN
$10.3B
-6,000
Closed -$770K
WY icon
2658
Weyerhaeuser
WY
$17.6B
-29,189
Closed -$724K
XBI icon
2659
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
-275,000
Closed -$27.6M
XBI icon
2660
State Street SPDR S&P Biotech ETF
XBI
$11.2B
-177,753
Closed -$17.8M
XENE icon
2661
Xenon Pharmaceuticals
XENE
$5.88B
-12,652
Closed -$508K
XLP icon
2662
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
-45,401
Closed -$3.56M
XLV icon
2663
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
-165,000
Closed -$23M
XLV icon
2664
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
-5,183
Closed -$721K
XMTR icon
2665
Xometry
XMTR
$4.79B
-4,644
Closed -$253K
XP icon
2666
XP
XP
$8.53B
-158,965
Closed -$2.99M
XPER icon
2667
Xperi
XPER
$305M
-21,457
Closed -$139K
XPEV icon
2668
XPeng
XPEV
$11.7B
-87,953
Closed -$2.06M
XRX icon
2669
Xerox
XRX
$381M
-9,338
Closed -$27.6K
XRT icon
2670
State Street SPDR S&P Retail ETF
XRT
$491M
-15,188
Closed -$1.31M
XYL icon
2671
Xylem
XYL
$26.5B
-3,393
Closed -$500K
YOU icon
2672
Clear Secure
YOU
$4.46B
-51,059
Closed -$1.7M
YPF icon
2673
YPF Sociedad Anonima ADS
YPF
$20.1B
-11,197
Closed -$272K
ZBH icon
2674
Zimmer Biomet
ZBH
$19.3B
-464,250
Closed -$866K
ZBRA icon
2675
Zebra Technologies
ZBRA
$17.4B
-21,764
Closed -$6.47M

Similar funds

Steve Schonfeld's Q4 2025 Portfolio in Review

As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
  • Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.